SARS-CoV-2 research and testing
The pandemic outbreak of new infectious diseases, like COVID-19 steadily increases the demand of test capabilities by point-of-care diagnostics. A rapid and decentralised testing of patients for pathogen or antibodies against SARS-CoV-2 together with a vaccination worldwide is crucial for the disease control and public health concerns.
Manufacturing of diagnostic chips
BioFluidix dispensing solutions help you with your processing work of any diagnostic chip layout with nanoliter or microliter volumes in R&D and production.
Precisely dispense ultra-low volumes of reagents and polymers into the cavities of your diagnostic chip. No matter, if your chip layout is circular, rectangular with one or multiple cavities. Deposit your desired droplet volume in any pattern on any layout of your point-of-care test device.
Vaccination worldwide
Coating or manufacturing of microneedle arrays with your therapeutic formulation for the vaccination against COVID-19 worldwide!
- Automated droplet volume calibration via SmartDrop System
- Vision recognition of microneedle array for an automated processing
- Dynamic droplet volume range in the nanoliter range
- Automated QC of hit-rate
Lateral flow testing
Development or manufacturing of test strips for the detection of antibodies against SARS-CoV-2
- non-contact processing of membranes or other substrates
- Print lines or any other droplet patterns
- Dynamic droplet volume range to adjust line width or spot size